EyePoint Pharmaceuticals, Inc.

Q4 2023 13F Holders

Symbol
EYPT
CUSIP
30233G209
Type
Equity
Class
COM NEW
Num filings
163
Total reported value, excl. options
$1.20 B
Manager Report Date Value ($000) Shares Option Type